Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
27.56
-0.50 (-1.78%)
Dec 19, 2025, 12:24 PM EST - Market open
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $851.95 million as of December 19, 2025. Its market cap has increased by 42.47% in one year.
Market Cap
851.95M
Enterprise Value
87.81M
1-Year Change
42.47%
Ranking
Category
Stock Price
$27.56
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $851.95M, an increase of 444.37%. That is a compound annual growth rate of 20.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 867.40M | 53.55% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |